PHARAMAECUTICAL INDUSTRY OF PAKISTAN ACKNOWLEDGEMENT All praises belong to almighty Allah who is the supreme authority knows the ultimate relations underlying all sorts of…
Report By: Anthonio Raphael Corteza Stephanie Joy Clemente BSN II-E Background y Every day, millions of parents seek health care for their sick children, taking them to hospitals,…
1. Pharmacovigilance: Regulators’ Perspective on Proactive Risk Management,Challenges & Collaborative Efforts with Pharma Companies• Dr. Bhaswat S. Chakraborty•…
1. This Provisional PDF corresponds to the article as it appeared upon acceptance. Fully formatted PDF and full text (HTML) versions will be made available soon. Effects…
Slide 1HOW DO WE GET THE ANTIBIOTICS WE NEED? Opportunities and challenges posed and lessons learned from recent submissions Dr. Flic Gabbay Senior Partner TranScrip Partners…
Slide 1The Global Alliance for TB Drug Development Gerald J. Siuta, Ph.D., CLP Consultant, Business Development Global Alliance for TB Drug Development Biotechnology Industry…
Slide 1TB Drug Development Gerald J. Siuta, Ph.D. Business Development May 3, 2007 Slide 2 Tuberculosis One-third of the worlds population is infected with Mycobacterium…
Slide 1Funding in Return for Rights Outside the Developed World: Public-Private Partnerships Gerald J. Siuta, Ph.D. Consultant, Business Development September 27, 2007 Slide…
Slide 1Off-Label Communications and the Public Health Presentation to the Pharmaceutical Compliance Forum November 8, 2007 Paul E. Kalb, M.D., J.D. With appreciation for…